AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
A senior lawmaker from Germany's Social Democrats, a junior partner in Chancellor Friedrich Merz's coalition government, called for a reassessment of ...
Pakistan's Defence Minister stated on Saturday that he believes Afghanistan desires peace, but warned that failure to reach an agreement during talks ...
Premier Li Qiang arrived in Singapore on Saturday for an official visit at the invitation of Singaporean Prime Minister Lawrence Wong....
Kyrgyzstan has launched a national stablecoin and central bank digital currency in collaboration with cryptocurrency exchange Binance, announced Presi...
The U.N. weather agency plans to cut some posts and is reviewing its priorities as dozens of countries, including the United States, are late with the...
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
At least 69 people have died and almost 150 injured following a powerful 6.9-magnitude earthquake off the coast of Cebu City in the central Visayas region of the Philippines, officials said, making it one of the country’s deadliest disasters this year.
A tsunami threat was issued in Chile after a magnitude 7.8 earthquake struck the Drake Passage on Friday. The epicenter was located 135 miles south of Puerto Williams on the north coast of Navarino Island.
The war in Ukraine has reached a strategic impasse, and it seems that the conflict will not be solved by military means. This creates a path toward one of two alternatives: either a “frozen” phase that can last indefinitely or a quest for a durable political regulation.
A shooting in Nice, southeastern France, left two people dead and five injured on Friday, authorities said.
Snapchat will start charging users who store more than 5GB of photos and videos in its Memories feature, prompting backlash from long-time users.
U.S. border czar says fentanyl should be considered a WMD.
U.S. states this week warned food aid recipients that their benefits may not be distributed in November if the federal government shutdown stretches into its fourth week.
The European Union is reportedly considering banning the use of ethanol as an active ingredient in biocidal products — including hand sanitisers — due to rising concerns about potential cancer risks, the Financial Times reported on Tuesday.
Johnson & Johnson (J&J) is facing its first lawsuits in the United Kingdom over claims that its talc-based products cause cancer, as it continues to battle tens of thousands of similar cases in the United States.
The World Health Organization on Monday issued a health advisory warning about three contaminated cough syrups identified in India, urging authorities to report any detection of these medicines in their countries to the health agency.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment